ID: ALA3623840

Max Phase: Preclinical

Molecular Formula: C18H25BrN2O2S

Molecular Weight: 332.47

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Br.CN1CC(O)(c2ccc(C3=NCCS3)cc2)OC2CCCCC21

Standard InChI:  InChI=1S/C18H24N2O2S.BrH/c1-20-12-18(21,22-16-5-3-2-4-15(16)20)14-8-6-13(7-9-14)17-19-10-11-23-17;/h6-9,15-16,21H,2-5,10-12H2,1H3;1H

Standard InChI Key:  WFXZAZQJJVWUDS-UHFFFAOYSA-N

Associated Targets(non-human)

Rattus norvegicus 775804 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Squalene synthetase 891 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Liver 4264 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 332.47Molecular Weight (Monoisotopic): 332.1558AlogP: 2.60#Rotatable Bonds: 2
Polar Surface Area: 45.06Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 10.92CX Basic pKa: 7.17CX LogP: 3.34CX LogD: 3.14
Aromatic Rings: 1Heavy Atoms: 23QED Weighted: 0.90Np Likeness Score: 0.58

References

1. Ladopoulou EM, Matralis AN, Nikitakis A, Kourounakis AP..  (2015)  Antihyperlipidemic morpholine derivatives with antioxidant activity: An investigation of the aromatic substitution.,  23  (21): [PMID:26433631] [10.1016/j.bmc.2015.09.034]

Source